Procoagulant abnormalities in cirrhosis with portal vein thrombosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24890816)

Published in Indian J Gastroenterol on September 01, 2014

Authors

Chhagan Bihari1, Priyanka Saxena, Archana Rastogi, Shasthry Sm, Ajeet Singh Bhadoria, Shvetank Sharma, Shiv Kumar Sarin

Author Affiliations

1: Department of Hematology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, Delhi, 110 070, India, drcbsharma@gmail.com.

Articles by these authors

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16

Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology (2011) 3.45

Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol (2002) 2.43

Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. J Gastroenterol Hepatol (2008) 2.09

Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med (2007) 1.89

Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res (2004) 1.73

Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol (2010) 1.66

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2011) 1.64

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. Hepatology (2011) 1.63

Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2012) 1.62

Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial. Eur J Gastroenterol Hepatol (2012) 1.53

Primary gastric lymphoma and Helicobacter pylori infection with gastric amyloidosis. Indian J Gastroenterol (2005) 1.48

Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: a case series. Indian J Gastroenterol (2014) 1.42

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology (2011) 1.34

Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis (2011) 1.31

Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology (2009) 1.29

Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19

Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey. Indian J Gastroenterol (2012) 1.14

Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol (2006) 1.11

Paederus dermatitis among residents of nursing hostel in central India: An outbreak investigation. Indian Dermatol Online J (2013) 1.11

Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol (2007) 1.09

Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci (2006) 1.09

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol (2013) 1.08

Upper gastrointestinal submucosal lesions--clinical and endosonographic evaluation and management. Trop Gastroenterol (2010) 1.08

Hepatic venous pressure gradient measurement: time to learn! Indian J Gastroenterol (2008) 1.07

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int (2008) 1.04

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2008) 1.03

Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99

Effect of peptide pools on effector functions of antigen-specific CD8+ T cells. J Immunol Methods (2009) 0.98

Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology (2012) 0.97

Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol (2009) 0.97

Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut (2010) 0.97

Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol (2012) 0.96

Downregulation of mitochondrial porin inhibits cell growth and alters respiratory phenotype in Trypanosoma brucei. Eukaryot Cell (2009) 0.95

Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol (2011) 0.95

Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology (2009) 0.93

Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells. Mol Cancer (2010) 0.93

Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology (2009) 0.92

Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci (2008) 0.92

Cystic pancreatic lymphangioma. The first report of a preoperative pathological diagnosis by endoscopic ultrasound-guided cyst aspiration. JOP (2011) 0.91

Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. J Clin Immunol (2011) 0.91

Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. J Clin Gastroenterol (2010) 0.91

Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.91

Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci (2012) 0.90

Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection. Clin Transl Gastroenterol (2012) 0.90

Conservative management of liver abscess complicated by hepatogastric fistula. Dig Liver Dis (2011) 0.89

A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. J Transl Med (2013) 0.89

Experimentally validated HERG pharmacophore models as cardiotoxicity prediction tools. J Chem Inf Model (2014) 0.88

Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med (2008) 0.88

Engineering challenges in biodiesel production from microalgae. Crit Rev Biotechnol (2012) 0.88

Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int (2010) 0.88

Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase. J Clin Immunol (2011) 0.87

Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. Eur J Gastroenterol Hepatol (2010) 0.87

Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol (2011) 0.87

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab (2013) 0.86

Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene (2011) 0.86

Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol (2011) 0.86

Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. J Clin Virol (2013) 0.86

Postinfantile giant cell hepatitis: an etiological and prognostic perspective. Hepat Res Treat (2013) 0.85

Hepatitis E- Is it a risk to transfusion safety? Asian J Transfus Sci (2013) 0.85

Tuberculosis of the spleen as a cause of Fever of unknown origin and splenomegaly. Gut Liver (2010) 0.84

Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci (2007) 0.84

Dieulafoy disease of the stomach presenting as mass lesion--a case report. Indian J Pathol Microbiol (2005) 0.83

Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure. Hepatology (2015) 0.83

Atypical metanephric adenoma - a case report and review of literature. Int Urol Nephrol (2007) 0.83

Inactivation of a gene for a fibronectin-binding protein of the oral bacterium Streptococcus mutans partially impairs its adherence to fibronectin. Microb Pathog (2008) 0.83

Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int (2008) 0.82

Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J Hepatol (2008) 0.82

Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. Clin Biochem (2011) 0.82

Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol (2009) 0.82

Etiology and prognostic factors of acute liver failure in children. Indian Pediatr (2012) 0.81

Lymphoepithelioma-like carcinoma: an unusual gall bladder tumour. Trop Gastroenterol (2015) 0.81

Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol (2009) 0.81

Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir. AIDS Res Hum Retroviruses (2013) 0.81

Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hepatol Int (2007) 0.81

Decrease in CD4+ T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine. Vaccine (2006) 0.81

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol (2008) 0.81

Eosinophilic abscesses: a new facet of hepatic visceral larva migrans. Abdom Imaging (2013) 0.81

Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India. Intervirology (2006) 0.80

Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy. J Gastroenterol Hepatol (2006) 0.80

Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF). Virchows Arch (2012) 0.80

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients. Indian J Pathol Microbiol (2010) 0.80

Assessment of iodine deficiency in school age children in Nainital District, Uttarakhand State. Asia Pac J Clin Nutr (2014) 0.80

Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch (2011) 0.79

Parvovirus b19 associated hepatitis. Hepat Res Treat (2013) 0.79

Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis (2012) 0.79

Impaired antigen processing and presentation machinery is associated with immunotolerant state in chronic hepatitis B virus infection. J Clin Immunol (2010) 0.79

Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection. J Gastroenterol Hepatol (2007) 0.79